DHR Danaher Corporation
company
SEC Filings & Insider Trading Activity 2026

CIK: 313616
Health Care
Industrial Instruments For Measurement, Display, and Control 32 filings
S&P 500

Latest Danaher Corporation (DHR) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on October 21, 2025, an 8-K current report filed on April 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Danaher Corporation (DHR) (SEC CIK 313616), with AI-powered section-by-section summaries updated daily.

10-Q: 18
8-K: 7
10-K: 7

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 24, 2026
10-Q Quarterly Report
Oct 21, 2025
8-K Current Report
Apr 29, 2026

AI 10-K Annual Report Analysis
Latest 10-K (2025-12-31)

Risk Factors

  • IEEPA tariff authority struck down by U.S. Supreme Court Feb 2026; administration pursuing new tariffs under alternative authority — full impact still uncertain
  • ~59% of 2025 sales from outside U.S.; China alone ~11% of sales, with government-mandated volume-based procurement programs actively suppressing prices
+3 more insights

Business Overview

  • Global science/technology platform across Biotechnology, Life Sciences, and Diagnostics segments; high recurring-revenue model via consumables and direct sales in ~50 countries
  • ~60,000 employees (associates) as of Dec 31, 2025; ~22,000 in North America, ~20,000 Western Europe, ~15,000 high-growth markets
+3 more insights

Management Discussion & Analysis

  • Revenue $24.6B, up 3.0% YoY; core sales +2.0% driven by Biotechnology (+6.5% core) and Diagnostics (+1.5% core), offset by Life Sciences (-1.5% core)
  • Operating margin 19.1% vs 20.4%; gross margin 59.1% vs 59.5%; SG&A 33.5% vs 32.5% of sales, pressured by $533M impairment charges
+3 more insights

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-26)

Management Discussion & Analysis

  • Revenue $6.05B Q3 2025, up 4.5% YoY; Nine months $17.73B, up 2.5% YoY, driven by Biotechnology and Diagnostics growth
  • Operating margin 19.1% Q3 2025 vs 16.5% YoY (+260 bps); Nine months margin 18.0% vs 19.8% YoY (-180 bps) due to impairments

Risk Factors

  • New trade policy risk due to U.S. tariffs and retaliatory tariffs impacting supply costs and pricing competitiveness
  • Material update on tariffs includes August 2025 U.S. Court ruling against certain tariffs, pending U.S. Supreme Court review
Read full Q3 2025 10-Q analysis →

Annual Reports Archive
10-K

AI-powered analysis of Danaher Corporation (DHR) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of Danaher Corporation (DHR) 10-Q quarterly reports filed with SEC EDGAR.

Financial Summary
XBRL

FY2022FY2023FY2024FY2025
Profitability
Revenue$23.9B$23.9B$24.6B
Gross Profit$18.9B$14.0B$14.2B$14.5B
Operating Income$5.2B$4.9B$4.7B
Net Income$4.8B$3.9B$3.6B
Gross Margin58.7%59.5%59.1%
Op. Margin21.8%20.4%19.1%
Net Margin19.9%16.3%14.7%
Balance Sheet
Total Assets$84.3B$84.5B$77.5B$83.5B
Equity$53.5B$49.5B$52.5B
ROE8.9%7.9%6.9%

Source: XBRL financial data from Danaher Corporation (DHR) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 29, 2026
8-K
Apr 21, 2026
8-K
Apr 17, 2026
10-K
Feb 24, 2026Dec 31, 2025Analysis
8-K
Feb 17, 2026
8-K
Feb 10, 2026
8-K
Jan 28, 2026
8-K
Jan 12, 2026
10-Q
Oct 21, 2025Sep 26, 2025Analysis
10-Q
Jul 22, 2025Jun 27, 2025Analysis
10-Q
Apr 22, 2025Mar 28, 2025Analysis
10-K
Feb 20, 2025Dec 31, 2024
10-Q
Oct 22, 2024Sep 27, 2024
10-Q
Jul 23, 2024Jun 28, 2024
10-Q
Apr 23, 2024Mar 29, 2024
10-K
Feb 21, 2024Dec 31, 2023
10-Q
Oct 24, 2023Sep 29, 2023
10-Q
Jul 25, 2023Jun 30, 2023
10-Q
Apr 25, 2023Mar 31, 2023
10-K
Feb 22, 2023Dec 31, 2022
10-Q
Oct 20, 2022Sep 30, 2022
10-Q
Jul 21, 2022Jul 1, 2022
10-Q
Apr 21, 2022Apr 1, 2022
10-K
Feb 23, 2022Dec 31, 2021
10-Q
Oct 21, 2021Oct 1, 2021

Frequently Asked Questions

What are the latest DHR SEC filings in 2026?

Danaher Corporation (DHR) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on October 21, 2025, an 8-K current report on April 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did DHR file its most recent 10-K annual report?

Danaher Corporation (DHR) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view DHR 10-Q quarterly reports?

Danaher Corporation (DHR)'s most recent 10-Q quarterly report was filed on October 21, 2025. SignalX displays every DHR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has DHR filed recently?

Danaher Corporation (DHR)'s most recent 8-K was filed on April 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find DHR insider trading activity (Form 4)?

SignalX aggregates every DHR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does DHR file with the SEC?

Danaher Corporation (DHR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new DHR filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Danaher Corporation (DHR).

What is DHR's SEC CIK number?

Danaher Corporation (DHR)'s SEC CIK (Central Index Key) number is 313616. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 313616 to look up all DHR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find DHR return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Danaher Corporation (DHR) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of Danaher Corporation SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 32+ filings.